Clinical Trial Update: Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Combretastatin A4 Phosphate in advanced anaplastic thyroid carcinoma (a form of head and neck cancer); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Head and Neck Cancer

Drugs mentioned

• Combretastatin A4 phosphate (combretastatin A4 phosphate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED